COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 3rd May 2020. As a result, our offices will now be closed till 3rd May 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details.,, Mob. 8826373757, 8826859373, 9910947804

Article view: 443

Article download: 158

IP International Journal of Maxillofacial Imaging

Chondroblastic variant of gnathic osteosarcoma– A rare case report

Full Text PDF Share on Facebook Share on Twitter

Author Details : Ashwini Baliga, Raghavendra Kini, Prasanna K. Rao, Roopashri Rajesh Kashyap, Meghana HC

Volume : 4, Issue : 2, Year : 2018

Article Page : 59-61

Suggest article by email


Osteosarcomas are the most common primary malignant neoplasm of the bone.  Osteosarcomas predominantly occur in the long bones and are rare in the maxillofacial region. Gnathic osteosarcoma differs from osteosarcoma of the long bones in its biological behavior even though they have the similar histologic appearance. The maxillary osteosarcomas show predilection for posterior portion of the alveolar process and the antrum, whereas in the mandible, body is most commonly involved site followed by angle, symphysis and ascending ramus. We report a rare case of osteosarcoma of the maxilla in a 62 year old male patient which was diagnosed histopathologically as chondroblastic variant of osteosarcoma. The treatment comprised of surgery followed by radiation therapy.

Keywords: Chondroblastic, Jaw, Osteosarcoma, Maxilla

Doi : 10.18231/2581-3838.2018.0015

How to cite : Baliga A, Kini R, Rao P K, Kashyap R R, Meghana Hc, Chondroblastic variant of gnathic osteosarcoma– A rare case report. IP Int J Maxillofac Imaging 2018;4(2):59-61

Copyright © 2018 by author(s) and IP Int J Maxillofac Imaging. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0) (